HealthEquity Inc.’s recent filing unveils that its Director Wellborn Gayle Furgurson unloaded Company’s shares for reported $0.32 million on Dec 14. In the deal valued at $62.00 per share,5,237 shares were sold. As a result of this transaction, Wellborn Gayle Furgurson now holds 12,023 shares worth roughly $ 0.78 million.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Then, Ladd Delano sold 5,897 shares, generating $442,275 in total proceeds. Upon selling the shares at $75.00, the EVP, GC & CORPORATE SECRETARY now owns 37,471 shares.
Before that, Trittschuh Larry L sold 11,526 shares. HealthEquity Inc. shares valued at $806,820 were divested by the EVP CHIEF SECURITY OFFICER at a price of $70.00 per share. As a result of the transaction, Trittschuh Larry L now holds 27,961 shares, worth roughly $1.81 million.
Goldman upgraded its HealthEquity Inc. [HQY] rating to a Neutral from a a Sell in a research note published on Friday, October 21, 2022; the price target was increased to $77 from $64. PT values the company’s stock at a premium of 16.01 to its Friday closing price. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. Goldman began covering HQY with “Sell” recommendation on July 12, 2022. Wells Fargo started covering the stock on April 11, 2022. It rated HQY as “an Overweight”.
Price Performance Review of HQY
On Friday, HealthEquity Inc. [NASDAQ:HQY] saw its stock fall -0.92% to $64.67. On the same session, the stock had its day’s lowest price of $64.27, but rose to a high of $65.995. Over the last five days, the stock has lost -2.16%. HealthEquity Inc. shares have risen nearly 4.92% since the year began. Nevertheless, the stocks have risen 20.88% over the past one year. While a 52-week high of $79.20 was reached on 02/16/23, a 52-week low of $50.35 was recorded on 02/02/23. SMA at 50 days reached $61.04, while 200 days put it at $63.96. A total of 0.64 million shares were traded, compared to the trading of 0.5 million shares in the previous session.
Levels Of Support And Resistance For HQY Stock
The 24-hour chart illustrates a support level at 63.96, which if violated will result in even more drops to 63.25. On the upside, there is a resistance level at 65.69. A further resistance level may holdings at 66.70. The Relative Strength Index (RSI) on the 14-day chart is 59.06, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.21, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 33.88%. Stochastics %K at 75.27% indicates the stock is a holding.
How much short interest is there in HealthEquity Inc.?
A steep rise in short interest was recorded in HealthEquity Inc. stocks on Jan 12, 2023, growing by 0.16 million shares to a total of 2.98 million shares. Yahoo Finance data shows the prior-month short interest on Dec 14, 2022 was 2.82 million shares. There was a rise of 5.37%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.04% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.9.
HealthEquity Inc. [HQY] – Who Are The Largest Shareholders?
In filings from BlackRock Fund Advisors, it is revealed that the company now owns 9,157,122 shares, or roughly 10.82% of the outstanding HQY shares. In other words, the investor’s shares have risen by 513,328 from its previous 13-F filing of 8643794.0. Additionally, The Vanguard Group, Inc. increased 1.78% of its stake after which the total value it holdings stand at $492,572,657, while Wasatch Advisors, Inc. added 0.10% of its stake to hold $348.79 million in the firm. Over the last quarter, Fidelity Management & Research Co purchased 307,894 shares of HealthEquity Inc., while William Blair Investment Manageme bought -347,008 shares. At present, SSgA Funds Management, Inc. is holding 2,697,875 shares valued at $164.17 million. Brown Advisory LLC owned 1,982,714 shares of the company at the time of its most recent 13F filing, worth $120.65 million.
According to FactSet, HealthEquity Inc.’s share price will average $82.23 in the next year, based on opinions of analysts polled by the firm. This is up nearly 28.7 percent from its previous closing price of $65.27. Analysts expect HealthEquity Inc. stock to reach the higher price of $94.00, while the lowest price estimate is $72.00. However, 13 analysts have rated HQY stock as a Buy in their predictions for 2023. The most recent change occurred on April 07, 2022 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $89 price target.